| Literature DB >> 30899158 |
P Parameswari1, R Devika2, P Vijayaraghavan3.
Abstract
In the present investigation, the bioactive compounds from the leaf extract of Artemisia nilagirica showed potent anti-inflammatory and antimicrobial activity. The leaf extract showed a maximum protection of human red blood cells (HRBC) with 74.63% at 20 µg/mL concentration, and the minimum hemolysis was 25.37% in a hypotonic solution with diclofenac as the control. The in vitro antimicrobial activity of plant extract against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi, Proteus vulgaris, Yersinia enterocolitica, Bacillus subtilis, and Candida albicans was evaluated at various concentrations (50, 100, 150, and 200 µg). The maximum zone of inhibition was observed against P. aeruginosa followed by B. subtilis, S. typhi, S. aureus and E. coli. The leaf extract also showed potent activity against C. albicans.Entities:
Keywords: Anti-bacterial; Anti-inflammatory; Antifungal; Medicinal plants
Year: 2018 PMID: 30899158 PMCID: PMC6408715 DOI: 10.1016/j.sjbs.2018.09.005
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
Fig. 1Percentage protection of Artemisia nilagirica (Clarke) Pamp leaf extract. Diclofenac was used as the control. The hemoglobin content in the supernatant was estimated using a UV–Visible spectrophotometer.
Fig. 2Percentage haemolytic effect of Artemisia nilagirica (Clarke) Pamp leaf extract. Diclofenac was used as the control. The hemoglobin content in the supernatant was estimated using a UV–Visible spectrophotometer.
Antimicrobial activity of plant extract from Artemisia nilagirica (Clarke) Pamp.
| Bacterial pathogens | Concentration of the leaf extract (µg) | Standard | |||
|---|---|---|---|---|---|
| 50 | 100 | 150 | 200 | ||
| 12 | 14 | 15 | 17 | 19 | |
| 11 | 13 | 15 | 18 | 20 | |
| 13 | 16 | 17 | 19 | 43 | |
| 12 | 14 | 16 | 18 | 40 | |
| 12 | 14 | 16 | 18 | 33 | |
| – | – | – | – | 13 | |
| – | – | – | – | 16 | |
| 3 | 6 | 8 | 10 | 12 | |